Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | Ildr2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ILDR2 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | decreases expression | ISO | Ildr2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of ILDR2 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ildr2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ILDR2 mRNA | CTD | PMID:26377647 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ILDR2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ildr2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ILDR2 mRNA | CTD | PMID:21889950 and PMID:26290441 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | Ildr2 (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:19467301 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Ildr2 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of ILDR2 exon | CTD | PMID:33297965 | 4-hydroxyphenyl retinamide | increases expression | ISO | Ildr2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of ILDR2 mRNA | CTD | PMID:28973697 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Ildr2 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of ILDR2 mRNA | CTD | PMID:28973697 | aflatoxin B1 | decreases expression | ISO | Ildr2 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of ILDR2 mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | multiple interactions | ISO | Ildr2 (Mus musculus) | 6480464 | [bisphenol A co-treated with Tretinoin] results in increased expression of ILDR2 mRNA | CTD | PMID:30951980 | atrazine | increases expression | ISO | ILDR2 (Homo sapiens) | 6480464 | Atrazine results in increased expression of ILDR2 mRNA | CTD | PMID:22378314 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Ildr2 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of ILDR2 mRNA | CTD | PMID:28085963 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ILDR2 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | Ildr2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of ILDR2 mRNA | CTD | PMID:32156529 | bisphenol A | decreases expression | ISO | Ildr2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of ILDR2 mRNA | CTD | PMID:33221593 | bisphenol A | multiple interactions | ISO | Ildr2 (Mus musculus) | 6480464 | [bisphenol A co-treated with Tretinoin] results in increased expression of ILDR2 mRNA | CTD | PMID:30951980 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ILDR2 mRNA | CTD | PMID:30816183 | bisphenol F | decreases expression | ISO | Ildr2 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of ILDR2 mRNA | CTD | PMID:30951980 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of ILDR2 mRNA | CTD | PMID:25993096 | cisplatin | increases expression | ISO | ILDR2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of ILDR2 mRNA | CTD | PMID:27392435 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of ILDR2 mRNA | CTD | PMID:24386269 | decabromodiphenyl ether | decreases expression | EXP | | 6480464 | decabromobiphenyl ether results in decreased expression of ILDR2 mRNA | CTD | PMID:23640034 | dibutyl phthalate | increases expression | ISO | Ildr2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of ILDR2 mRNA | CTD | PMID:21266533 | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of ILDR2 mRNA | CTD | PMID:25152437 | dorsomorphin | multiple interactions | ISO | ILDR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | ILDR2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of ILDR2 mRNA | CTD | PMID:29803840 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of ILDR2 mRNA | CTD | PMID:29391264 | entinostat | decreases expression | ISO | ILDR2 (Homo sapiens) | 6480464 | entinostat results in decreased expression of ILDR2 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | ILDR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ILDR2 mRNA | CTD | PMID:27188386 | ethanol | increases expression | ISO | Ildr2 (Mus musculus) | 6480464 | Ethanol results in increased expression of ILDR2 mRNA | CTD | PMID:19167417 and PMID:30319688 | ethanol | multiple interactions | ISO | Ildr2 (Mus musculus) | 6480464 | Ethanol affects the expression of and affects the splicing of ILDR2 mRNA | CTD | PMID:30319688 | fluoranthene | multiple interactions | ISO | Ildr2 (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of ILDR2 mRNA | CTD | PMID:28329830 | folic acid | decreases expression | ISO | Ildr2 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ILDR2 mRNA | CTD | PMID:25629700 | FR900359 | decreases phosphorylation | ISO | ILDR2 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of ILDR2 protein | CTD | PMID:37730182 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of ILDR2 mRNA | CTD | PMID:33387578 | inulin | multiple interactions | ISO | Ildr2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ILDR2 mRNA | CTD | PMID:36331819 | leflunomide | decreases expression | ISO | Ildr2 (Mus musculus) | 6480464 | leflunomide results in decreased expression of ILDR2 mRNA | CTD | PMID:19751817 | methotrexate | increases expression | ISO | ILDR2 (Homo sapiens) | 6480464 | Methotrexate results in increased expression of ILDR2 mRNA | CTD | PMID:24449571 | methyl methanesulfonate | increases expression | ISO | ILDR2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of ILDR2 mRNA | CTD | PMID:23649840 | nickel sulfate | decreases expression | ISO | ILDR2 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of ILDR2 mRNA | CTD | PMID:22714537 | paracetamol | affects expression | ISO | Ildr2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of ILDR2 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ILDR2 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ildr2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ILDR2 mRNA more ... | CTD | PMID:36331819 | phenobarbital | affects expression | ISO | Ildr2 (Mus musculus) | 6480464 | Phenobarbital affects the expression of ILDR2 mRNA | CTD | PMID:23091169 | pirinixic acid | decreases expression | ISO | Ildr2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of ILDR2 mRNA | CTD | PMID:23811191 | resveratrol | multiple interactions | ISO | Ildr2 (Mus musculus) | 6480464 | Resveratrol inhibits the reaction [titanium dioxide results in increased expression of ILDR2 mRNA] | CTD | PMID:31298478 | resveratrol | multiple interactions | ISO | ILDR2 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of ILDR2 mRNA | CTD | PMID:23557933 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of ILDR2 mRNA | CTD | PMID:28374803 | SB 431542 | multiple interactions | ISO | ILDR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | decreases expression | ISO | ILDR2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ILDR2 mRNA | CTD | PMID:22714537 | sodium arsenite | decreases expression | ISO | Ildr2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of ILDR2 mRNA | CTD | PMID:37682722 | sodium dichromate | decreases expression | EXP | | 6480464 | sodium bichromate results in decreased expression of ILDR2 mRNA | CTD | PMID:25993096 | tetrachloromethane | increases expression | ISO | Ildr2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of ILDR2 mRNA | CTD | PMID:17484886 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of ILDR2 mRNA | CTD | PMID:31150632 | titanium dioxide | multiple interactions | ISO | Ildr2 (Mus musculus) | 6480464 | Resveratrol inhibits the reaction [titanium dioxide results in increased expression of ILDR2 mRNA] | CTD | PMID:31298478 | titanium dioxide | increases expression | ISO | Ildr2 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of ILDR2 mRNA | CTD | PMID:31298478 | trichostatin A | decreases expression | ISO | ILDR2 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of ILDR2 mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | ISO | ILDR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ILDR2 mRNA | CTD | PMID:27188386 | triclosan | decreases expression | ISO | ILDR2 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of ILDR2 mRNA | CTD | PMID:30510588 | triptonide | increases expression | ISO | Ildr2 (Mus musculus) | 6480464 | triptonide results in increased expression of ILDR2 mRNA | CTD | PMID:33045310 | valproic acid | increases methylation | ISO | ILDR2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of ILDR2 gene | CTD | PMID:29154799 | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of ILDR2 mRNA | CTD | PMID:29427782 | valproic acid | affects expression | ISO | Ildr2 (Mus musculus) | 6480464 | Valproic Acid affects the expression of ILDR2 mRNA | CTD | PMID:17963808 | valproic acid | increases expression | ISO | ILDR2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ILDR2 mRNA | CTD | PMID:23179753 | valproic acid | decreases expression | ISO | ILDR2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ILDR2 mRNA | CTD | PMID:24383497 and PMID:26272509 | valproic acid | multiple interactions | ISO | ILDR2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ILDR2 mRNA | CTD | PMID:27188386 | vincristine | decreases expression | ISO | ILDR2 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of ILDR2 mRNA | CTD | PMID:23649840 | |